HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Liver hematoma — Clinical Guidelines

Overview

Liver hematoma refers to localized bleeding within the liver parenchyma, often secondary to trauma or underlying liver pathology, and can present as a subcapsular collection mimicking other hepatic conditions like metastases. 9

Diagnosis

Imaging: Ultrasonography, CT, and MRI are crucial for identifying hematoma characteristics, including echogenicity and size 9 13.

Ultrasonography: Can reveal sonolucent areas indicative of necrosis or hematoma 13.

CT: Useful for detailed anatomical assessment and distinguishing from calcified metastases 11 15.

MRI: Provides additional soft tissue contrast, aiding in differentiation from other lesions 8.

LFTs: Elevated liver enzymes may accompany hematoma but are non-specific 14.

Management

Conservative Management: Often sufficient for asymptomatic subcapsular hematomas, with close monitoring 9.

Palliative Radiotherapy: Used for symptomatic relief in cases with massive liver metastases, delivering doses like 17 Gy in multiple fractions 6 14.

Interventional Radiology: Techniques such as radiofrequency ablation, cryotherapy, and laser-induced thermotherapy (LITT) are employed for localized treatment of hepatic lesions, though not specifically for hematomas 7 8.

Special Populations

Pregnancy: Subcapsular hematomas can occur, often associated with HELLP syndrome; conservative management is typically recommended with extended postpartum follow-up 9.

Key Recommendations

Monitor Asymptomatic Hematomas Closely: Regular imaging follow-up is essential to monitor resolution or complications 9 (Evidence: Moderate).

Palliative Radiotherapy for Symptomatic Cases: Effective for symptom relief in patients with massive liver metastases, using regimens like 17 Gy in multiple fractions 6 14 (Evidence: Moderate).

Avoid Unnecessary Interventions: Conservative management suffices for many subcapsular hematomas unless there are signs of rupture or significant symptoms 9 (Evidence: Expert opinion).

References

1 Franzese C, Louie AV, Kotecha R, Zhang Z, Guckenberger M, Kim MS et al.. Stereotactic Body Radiation therapy for Liver Metastases: Systematic Review and Meta-Analysis With International Stereotactic Radiosurgery Society (ISRS) Practice Guidelines. Practical radiation oncology 2025. link 2 Ito K, Ogoshi Y, Shimizuguchi T. Palliative radiotherapy for multiple liver metastases: a retrospective analysis of 73 cases. Japanese journal of clinical oncology 2022. link 3 Nishioka Y, Odisio BC, Velasco JD, Ninan E, Huang SY, Mahvash A et al.. Fast-track two-stage hepatectomy by concurrent portal vein embolization at first-stage hepatectomy in hybrid interventional radiology / operating suite. Surgical oncology 2021. link 4 Carr MJ, Sun J, Cohen JB, Liu J, Serdiuk AA, Stewart SR et al.. Over 12 Years Single Institutional Experience Performing Percutaneous Hepatic Perfusion for Unresectable Liver Metastases. Cancer control : journal of the Moffitt Cancer Center 2020. link 5 Cornelis F, Sotirchos V, Violari E, Sofocleous CT, Schoder H, Durack JC et al.. 18F-FDG PET/CT Is an Immediate Imaging Biomarker of Treatment Success After Liver Metastasis Ablation. Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2016. link 6 Edyta WR, Jakub L, Jerzy W. Whole Liver Palliative Radiotherapy for Patients with Massive Liver Metastases. Asian Pacific journal of cancer prevention : APJCP 2015. link 7 Adam A. Interventional radiology in the treatment of hepatic metastases. Cancer treatment reviews 2002. link 8 Vogl TJ, Mack MG, Straub R, Roggan A, Felix R. Magnetic resonance imaging--guided abdominal interventional radiology: laser-induced thermotherapy of liver metastases. Endoscopy 1997. link 9 Lavery JP, Berg J. Subcapsular hematoma of the liver during pregnancy. Southern medical journal 1989. link 10 Weiss GR, Garnick MB, Osteen RT, Steele GD, Wilson RE, Schade D et al.. Long-term hepatic arterial infusion of 5-fluorodeoxyuridine for liver metastases using an implantable infusion pump. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1983. link 11 Bernardino ME. Computed tomography of calcified liver metastases. Journal of computer assisted tomography 1979. link 12 Joo KG, Carter JE. Extrinsic lesions simulating hepatic metastases. Clinical nuclear medicine 1979. link 13 Wooten WB, Green B, Goldstein HM. Ultrasonography of necrotic hepatic metastases. Radiology 1978. link 14 Mäntylä M, Nordman E. Radiation treatment of liver metastases. Strahlentherapie 1978. link 15 Katragadda CS, Goldstein HM, Green B. Gray scale ultrasonography of calcified liver metastases. AJR. American journal of roentgenology 1977. link 16 Turek-Maischeider M, Kazem I. Palliative irradiation for liver metastases. JAMA 1975. link

Liver hematoma